Curis
CRIS
#11081
Rank
C$0.94 M
Marketcap
C$0.49
Share price
-17.89%
Change (1 day)
-78.38%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2026 (TTM): C-$33.22

According to Curis's latest financial reports the company's current EPS (TTM) is C-$33.36. In 2025 the company made an earnings per share (EPS) of C-$33.36 an increase over its 2024 EPS that were of C-$197.08.

EPS history for Curis from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$33.22-0.43%
2025C-$33.36-83.07%
2024C-$197.08-22.15%
2023C-$253.15-26.17%
2022C-$342.8622.3%
2021C-$280.34-25.37%
2020C-$375.66-30.93%
2019C-$543.86-2.02%
2018C-$555.07
2016C-$1,262-10%
2015C-$1,402138.1%
2014C-$588.7140%
2013C-$420.51-25%
2012C-$560.6866.67%
2011C-$336.41

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
C$1.84-105.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$4.99-114.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
C-$0.50-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
C$4.39-113.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
C-$5.97-82.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
C-$7.06-78.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C-$0.24-99.29%๐Ÿ‡บ๐Ÿ‡ธ USA